Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
ADMA and SDMA are methylated derivatives of the amino acid arginine that serve as markers of endothelial dysfunction and kidney function, respectively.
ADMA and SDMA are biomarkers for cardiovascular and renal health.
Key facts at a glance
- Units
- μmol/L
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche ADMA/SDMA, Immunodiagnostic ADMA/SDMA
ADMA and SDMA are amino acid derivatives that play significant roles in cardiovascular and renal physiology. Elevated levels of ADMA are associated with endothelial dysfunction, a precursor to cardiovascular diseases, while SDMA is a marker for kidney function and can indicate renal impairment.
These biomarkers are measured through blood tests and are crucial for assessing the risk of cardiovascular events and monitoring kidney health. They are particularly useful in patients with hypertension, diabetes, and chronic kidney disease.
Normal levels of ADMA and SDMA range from 0 to 1 μmol/L. Elevated levels may necessitate further diagnostic evaluation and intervention to manage cardiovascular and renal risks.
Frequently asked questions
What are the normal levels of ADMA and SDMA?
What do elevated levels of ADMA and SDMA indicate?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy